Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 2/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20176091 | 0.87 | CTSS (0.33) | EBPSIGMAR1DRD2DRD4OPRM1 | |
| SCHEMBL20176083 | 0.83 | DRD2 (0.35) | EBPSIGMAR1DRD2DRD4OPRM1 | |
| SCHEMBL20176092 | 0.82 | DRD2 (0.35) | EBPSIGMAR1DRD2DRD4OPRM1 | |
| SCHEMBL20176072 | 0.82 | DRD2 (0.35) | EBPSIGMAR1DRD2DRD4OPRM1 | |
| SCHEMBL6724280 | 0.82 | DRD2 (0.38) | EBPSIGMAR1DRD2DRD4OPRM1 | |
| SCHEMBL20176087 | 0.80 | DRD2 (0.33) | EBPSIGMAR1DRD2DRD4OPRM1 | |
| SCHEMBL20176074 | 0.78 | DRD2 (0.32) | EBPSIGMAR1DRD2DRD4OPRM1 | |
| SCHEMBL20176089 | 0.77 | TRPV1 (0.33) | DRD2DRD4OPRM1DRD3CTSS | |
| SCHEMBL20176084 | 0.77 | DRD2 (0.35) | EBPSIGMAR1DRD2DRD4OPRM1 | |
| SCHEMBL20176086 | 0.77 | DRD2 (0.35) | EBPSIGMAR1DRD2DRD4OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180141964-A1 | FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF | EAST CHINA NORMAL UNIVERSITY (CN) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141964-A1 | FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF | NCLN, PNN, MB | EBP 951/4885SIGMAR1 827/4885DRD2 2601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.